Kindora
FeaturesSocial Impact InvestmentsPricing
AboutLive Demos
Sign InSign Up
    Kindora
    FeaturesSocial Impact InvestmentsPricing
    AboutLive Demos
    Sign InSign Up
    1. Home
    2. Foundations
    3. Merck Patient Assistance Program
    Merck Patient Assistance Program logo

    Merck Patient Assistance Program

    ActivePhilanthropy & VoluntarismFunds Individuals
    Rahway, NJWebsiteEIN: 01-05755203 filings on record

    About Merck Patient Assistance Program

    The Merck Patient Assistance Program overwhelmingly directs funding to provide Merck prescription medicines and adult vaccines to uninsured or underinsured patients, primarily via its Patient Assistance Program and very large programmatic disbursements. Giving is highly concentrated into a handful of extremely large awards—likely reflecting in‑kind medication donations or centralized program funding to serve individual patients and partner providers. This reflects a narrow, operational focus on medication access rather than diversified philanthropic grants.

    Who They Fund

    uninsured patientslow-income patients with financial barriers to medicinespatients requiring adult vaccines

    Giving Approach

    Very few, extremely large grants concentrated on programmatic/in‑kind support for medication and vaccine access

    Funding Style

    direct servicein-kind medication donationmeans-tested/eligibility-based assistanceaccess-focused patient support

    Notable grantees: Various (recipients of the Merck Patient Assistance Program), See Statement 4 (unspecified large recipient), Merck Patient Assistance Program Inc. (program operations)

    About Merck Patient Assistance Program

    Merck Patient Assistance Program Inc directs almost all of its giving toward one purpose: making Merck medicines and adult vaccines available at no charge to eligible patients who lack insurance coverage or cannot afford treatment. The organization’s recent grants are unusually large and programmatic, reflecting a centralized assistance model rather than a broad portfolio of discretionary philanthropy. In the latest grant list, one award of $1,952,689,147 went to "Various" in New Jersey for Merck PAP support, and another award of $1,911,974,863 was listed for "See Statement 4" in Rahway, New Jersey. These entries point to a funding structure built around high-volume medication access, bulk replenishment, and patient assistance administration. The foundation’s work is concentrated on prescription medicines and adult vaccines, with eligibility tied to income and insurance status. Rather than funding a wide range of nonprofits, it operates through patient assistance programs that serve uninsured people and safety-net facilities. The result is a narrow but highly specific charitable profile centered on access to essential Merck products.

    What Merck Patient Assistance Program Funds

    The clearest theme in Merck Patient Assistance Program Inc’s grantmaking is medication access. A 2024 grant of $1,952,689,147 to "Various" in New Jersey supported Merck PAP, which provides certain Merck medicines and adult vaccines free to eligible patients without insurance coverage. Adult vaccination access is also central: the Merck Vaccine Patient Assistance Program offers certain Merck adult vaccines free of charge to eligible adults who cannot afford them. The foundation also supports facility-level distribution through bulk replacement programs for eligible sites serving large numbers of low-income, uninsured patients. For individual medicine access, the Merck Patient Assistance Program provides certain Merck medicines free to eligible individuals, with a single application able to cover up to one year of medicine.

    How Merck Patient Assistance Program Gives

    Grant sizes are extremely concentrated: the 25th percentile is $1,766,476,375, the median is $1,828,547,299, and the 75th percentile is $1,890,618,223. That distribution shows a small band of very large awards rather than a wide spread of gift sizes. The pattern also suggests recurring program funding, since the recent grants list shows similarly sized awards across 2023, 2024, and 2025. Merck Patient Assistance Program Inc is a regular funder, not a DAF, and it makes grants to individuals. The structure is operational and eligibility-based, with support delivered through patient assistance programs and bulk replacement arrangements rather than an open competitive grant process.

    Financial Snapshot

    Annual Giving

    $5.6B

    Total Assets

    $26.4M

    Total Revenue

    $1.9B

    Total Expenses

    $1.9B

    Typical Grant Size

    Most grants fall between $1.8B and $1.9B, with a median of $1.8B.

    25th Percentile

    $1.8B

    Median

    $1.8B

    75th Percentile

    $1.9B

    Geographic Reach

    Local1 state funded

    About 100% of grants go to recipients in NJ.

    Funding intensity
    Low
    High
    Headquarters

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    Want a Personalized Pitch for Merck Patient Assistance Program?

    Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.

    Get Started FreeView Pricing
    Free plan available
    No contracts
    Cancel anytime
    Free Weekly Newsletter

    The Grant Brief

    Weekly grant intelligence for social impact leaders. Curated opportunities, funding trends, and strategic insights — free.

    Join 500+ social impact leaders. Unsubscribe anytime. Privacy Policy

    Trusted by mission-driven teams at organizations nationwide

    Kindora Logo

    At Kindora, we combine data-driven insights with a human touch to create meaningful, strategic fundraising solutions for mission-driven organizations of all sizes.

    Get The Grant Brief — free weekly grant intelligence

    Quick Links

    • Features
    • Social Impact Investments
    • About Us
    • Mission
    • How It Works
    • Pricing
    • Sales deck
    • Philanthropy Jobs
    • Nonprofit Compensation
    • Live demo (every plan)
    • Individual prospecting demoBeta
    • Blog
    • FAQ
    • Getting Started

    Connect With Us

    LinkedInTwitterFacebook

    © 2026 Kindora. All rights reserved.

    Privacy PolicyTerms of ServiceSystem Status
    See If You're a Fit — FreeFree account · instant fit score · similar funders

    Topics

    medication access programsadult vaccination provisionpharmaceutical patient assistancemedication affordability and cost relief

    Where Merck Patient Assistance Program Makes Grants

    Giving is geographically narrow. Every recent grant in the provided data went to recipients in the United States, and 100% of grants were given to recipients in New Jersey. Recipient locations in the recent grants include Various, NJ and Rahway, NJ. The active program descriptions also show U.S.-based service delivery, with patient assistance and bulk replacement programs focused on eligible facilities and individuals in the United States.

    Frequently Asked Questions About Merck Patient Assistance Program

    What does Merck Patient Assistance Program Inc mainly fund?

    It primarily funds access to Merck medicines and adult vaccines for eligible patients who are uninsured or underinsured. The recent grants and program descriptions center on patient assistance, bulk replacement, and free product provision rather than a broad mix of charitable causes.

    How large are its typical grants?

    Its grant sizes are very large and tightly clustered. The 25th percentile is $1,766,476,375, the median is $1,828,547,299, and the 75th percentile is $1,890,618,223.

    Does it fund only organizations, or individuals too?

    It funds individuals as well as program delivery structures. The program descriptions include direct patient assistance for eligible individuals and bulk replacement support for facilities serving large numbers of low-income, uninsured patients.

    Where are its grants concentrated geographically?

    The recent grants in the data are entirely U.S.-based, and 100% were given to recipients in New Jersey. Recipient locations listed include Various, NJ and Rahway, NJ.

    Are the grants recurring or one-time?

    The recent grant list shows similarly large awards in 2023, 2024, and 2025, which indicates repeated program funding over multiple years rather than a single isolated award.

    Latest 990 Filing

    2025

    Source: IRS Form 990-PF, fiscal year 2025.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    See Statement 4Rahway, NJ$1,911,974,8632025N A
    VariousVarious, NJ$1,952,689,1472024The Merck Patient Assistance Program Inc. Merck PAP provides certain Merck medicines and adult vaccines for free to eligible patients who do not have insurance coverage or who without Mercks assistance cannot afford their Merck medicine and vaccines.
    VariousVarious, NJ$1,704,405,4512023Assisting various patients in medical and financial need. The Merck Patient Assistance Program inc. Merck PAP provides certain Merck medicines and adult vaccines for free to eligible patients who do not have insurance coverage or who without assistance cannot afford their Merck medicine and vaccines.

    See Statement 4

    $1,911,974,863
    Rahway, NJ2025

    N A

    Various

    $1,952,689,147
    Various, NJ2024

    The Merck Patient Assistance Program Inc. Merck PAP provides certain Merck medicines and adult vaccines for free to eligible patients who do not have insurance coverage or who without Mercks assistance cannot afford their Merck medicine and vaccines.

    Various

    $1,704,405,451
    Various, NJ2023

    Assisting various patients in medical and financial need. The Merck Patient Assistance Program inc. Merck PAP provides certain Merck medicines and adult vaccines for free to eligible patients who do not have insurance coverage or who without assistance cannot afford their Merck medicine and vaccines.